ID: ALA4865471

Max Phase: Preclinical

Molecular Formula: C20H21N3O5S

Molecular Weight: 415.47

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(=O)NC(=O)c1ccsc1NC(=O)c1ccc(C(=O)N2CCCCC2)cc1

Standard InChI:  InChI=1S/C20H21N3O5S/c1-28-20(27)22-17(25)15-9-12-29-18(15)21-16(24)13-5-7-14(8-6-13)19(26)23-10-3-2-4-11-23/h5-9,12H,2-4,10-11H2,1H3,(H,21,24)(H,22,25,27)

Standard InChI Key:  HBXACXQRFJZTFF-UHFFFAOYSA-N

Associated Targets(Human)

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HERG 29587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mycobacterium tuberculosis 203094 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vero 26788 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase 247 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 415.47Molecular Weight (Monoisotopic): 415.1202AlogP: 3.12#Rotatable Bonds: 4
Polar Surface Area: 104.81Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.11CX Basic pKa: CX LogP: 3.27CX LogD: 2.05
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.80Np Likeness Score: -1.72

References

1. Wang P, Batt SM, Wang B, Fu L, Qin R, Lu Y, Li G, Besra GS, Huang H..  (2021)  Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities.,  64  (9.0): [PMID:33852302] [10.1021/acs.jmedchem.1c00263]
2. Qin R, Wang P, Wang B, Fu L, Batt SM, Besra GS, Wu C, Wang Y, Huang H, Lu Y, Li G..  (2022)  Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis.,  231  [PMID:35101648] [10.1016/j.ejmech.2022.114145]

Source